A highly heterogeneous HIV-1 epidemic in the Central African Republic

被引:14
作者
Massanga, M
Ndoyo, J
Hu, DJ
Pau, CP
LeeThomas, S
Hawkins, R
Senekian, D
Rayfield, MA
George, JR
Zengais, A
Yatere, NN
Yossangang, V
Samori, A
Schochetman, G
Dondero, TJ
机构
[1] Centers for Dis. Contr. and Prev., Atlanta, GA
关键词
D O I
10.3201/eid0203.960310
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:222 / 224
页数:3
相关论文
共 12 条
[1]   ISOLATION AND PARTIAL CHARACTERIZATION OF AN UNUSUAL HUMAN IMMUNODEFICIENCY RETROVIRUS FROM 2 PERSONS OF WEST-CENTRAL AFRICAN ORIGIN [J].
DELEYS, R ;
VANDERBORGHT, B ;
VANDENHAESEVELDE, M ;
HEYNDRICKX, L ;
VANGEEL, A ;
WAUTERS, C ;
BERNAERTS, R ;
SAMAN, E ;
NIJS, P ;
WILLEMS, B ;
TAELMAN, H ;
VANDERGROEN, G ;
PIOT, P ;
TERSMETTE, T ;
HUISMAN, JG ;
VANHEUVERSWYN, H .
JOURNAL OF VIROLOGY, 1990, 64 (03) :1207-1216
[2]  
GURTLER LG, 1994, J VIROL, V68, P1581
[3]   The emerging genetic diversity of HIV - The importance of global surveillance for diagnostics, research, and prevention [J].
Hu, DJ ;
Dondero, TJ ;
Rayfield, MA ;
George, JR ;
Schochetman, G ;
Jaffe, HW ;
Luo, CC ;
Kalish, ML ;
Weniger, BG ;
Pau, CP ;
Schable, CA ;
Curran, JW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03) :210-216
[4]  
LAGA M, 1991, AIDS, V5, pS55
[5]   HIV-1/HIV-2 SERONEGATIVITY IN HIV-1 SUBTYPE-O INFECTED PATIENTS [J].
LOUSSERTAJAKA, I ;
BRUNVEZINET, F ;
SIMON, F ;
LY, TD ;
CHAIX, ML ;
SARAGOSTI, S ;
COUROUCE, AM ;
INGRAND, D .
LANCET, 1994, 343 (8910) :1393-1394
[6]   HIV SEROPREVALENCE AND MALE TO FEMALE RATIO IN CENTRAL AFRICA [J].
MATHIOT, CC ;
LEPAGE, C ;
CHOUAIB, E ;
GEORGESCOURBOT, MC ;
GEORGES, AJ .
LANCET, 1990, 335 (8690) :672-672
[7]   DIVERSITY OF V3 REGION SEQUENCES OF HUMAN IMMUNODEFICIENCY VIRUSES TYPE-1 FROM THE CENTRAL-AFRICAN-REPUBLIC [J].
MURPHY, E ;
KORBER, B ;
GEORGESCOURBOT, MC ;
YOU, B ;
PINTER, A ;
COOK, D ;
KIENY, MP ;
GEORGES, A ;
MATHIOT, C ;
BARRESINOUSSI, F ;
GIRARD, M .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (10) :997-1006
[8]   ANTIGENIC VARIATION AND SEROTYPING OF HIV TYPE-1 FROM 4 WORLD-HEALTH-ORGANIZATION-SPONSORED HIV VACCINE SITES [J].
PAU, CP ;
KAI, M ;
HOLLOMANCANDAL, DL ;
LUO, CC ;
KALISH, ML ;
SCHOCHETMAN, G ;
BYERS, B ;
GEORGE, JR ;
OSMANOV, S ;
BELSEY, EM ;
HEYWARD, W ;
ESPARZA, J ;
GALVAOCASTRO, B ;
VANDEPERRE, P ;
KARITA, E ;
WASI, C ;
SEMPALA, S ;
TUGUME, B ;
BIRYAHWAHO, B ;
RUBSAMENWAIGMANN, H ;
VONBRIESEN, H ;
ESSER, R ;
GREZ, M ;
HOLMES, H ;
NEWBERRY, A ;
RANJBAR, S ;
TOMLINSON, P ;
BRADAC, J ;
MCCUTCHAN, F ;
LOUWAGIE, J ;
HEGERICH, P ;
LOPEZGALINDEZ, C ;
OLIVARES, I ;
DOPAZO, J ;
MULLINS, JI ;
DELWART, EL ;
BACHMANN, HM ;
GOUDSMIT, J ;
DEWOLF, F ;
HAHN, BH ;
GAO, F ;
YUE, L ;
SARAGOSTI, S ;
KALISH, M ;
GEORGE, R ;
WEBER, J ;
CHEINGSONGPOPOV, R ;
KALEEBU, P ;
NARA, P ;
FENYO, EM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (11) :1369-1377
[9]   Surveillance for human immunodeficiency virus type 1 group O infections in the United States [J].
Pau, CP ;
Hu, DJ ;
Spruill, C ;
Schable, C ;
Lackritz, E ;
Kai, M ;
George, JR ;
Rayfield, MA ;
Dondero, TJ ;
Williams, AE ;
Busch, MP ;
Brown, AE ;
McCutchan, FE ;
Schochetman, G .
TRANSFUSION, 1996, 36 (05) :398-400
[10]   SENSITIVITY OF UNITED-STATES HIV ANTIBODY TESTS FOR DETECTION OF HIV-1 GROUP-O INFECTIONS [J].
SCHABLE, C ;
ZEKENG, L ;
PAU, CP ;
HU, D ;
KAPTUE, L ;
GURTLER, L ;
DONDERO, T ;
TSAGUE, JM ;
SCHOCHETMAN, G ;
JAFFE, H ;
GEORGE, JR .
LANCET, 1994, 344 (8933) :1333-1334